Colin C Pritchard Selected Research

Colin C Pritchard Research Topics

Disease

55	Neoplasms (Cancer) 12/2023 - 03/2011
41	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 05/2015
10	Microsatellite Instability 03/2020 - 12/2014
8	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 11/2010
6	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 07/2023 - 12/2014
5	Neoplasm Metastasis (Metastasis) 01/2023 - 10/2016
5	Carcinoma (Carcinomatosis) 01/2023 - 02/2014
5	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2013
4	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2020 - 01/2017
2	Adenocarcinoma 05/2019 - 01/2019
2	Turcot syndrome 12/2018 - 12/2014
1	Neuroendocrine Carcinoma 01/2023
1	Genomic Instability 12/2022
1	Urogenital Neoplasms 05/2021
1	Xeroderma Pigmentosum (Kaposi's Disease) 01/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Sepsis (Septicemia) 11/2018
1	Brain Injuries (Brain Injury) 11/2018
1	Brain Neoplasms (Brain Tumor) 07/2018
1	Ovarian Neoplasms (Ovarian Cancer) 03/2017
1	Ovarian Epithelial Carcinoma 03/2017
1	Leukemia 01/2016
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Disease Progression 01/2016
1	Endometrial Neoplasms (Endometrial Cancer) 12/2014
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 10/2014
1	Polyps 10/2014
1	Sarcoma (Soft Tissue Sarcoma) 08/2014
1	Leiomyosarcoma 08/2014
1	Colonic Neoplasms (Colon Cancer) 07/2012
1	Hemolysis 03/2012

Drug/Important Bio-Agent (IBA)

20	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 12/2014
17	Proteins (Proteins, Gene)FDA Link 07/2023 - 10/2014
15	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2011
7	PlatinumIBA 12/2023 - 02/2014
6	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2022 - 02/2014
6	Immune Checkpoint InhibitorsIBA 01/2021 - 05/2019
5	Circulating Tumor DNAIBA 12/2023 - 01/2018
5	NucleotidesIBA 01/2023 - 07/2012
5	Hormones (Hormone)IBA 01/2023 - 01/2020
5	ErbB Receptors (EGF Receptor)IBA 01/2022 - 11/2010
5	ParaffinIBA 07/2018 - 11/2010
5	Formaldehyde (Formol)FDA Link 07/2018 - 11/2010
4	pembrolizumabIBA 12/2021 - 01/2018
4	MicroRNAs (MicroRNA)IBA 07/2014 - 03/2011
3	AndrogensIBA 12/2023 - 01/2019
3	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 01/2019
3	abirateroneIBA 01/2022 - 01/2017
3	Cell-Free Nucleic AcidsIBA 06/2021 - 01/2019
3	Epithelial Cell Adhesion MoleculeIBA 01/2018 - 07/2012
2	AntigensIBA 01/2022 - 01/2020
2	enzalutamideIBA 01/2020 - 01/2017
2	Tumor Biomarkers (Tumor Markers)IBA 01/2018 - 03/2012
1	177Lu-PSMA-617IBA 04/2024
1	Nucleosomes (Nucleosome)IBA 01/2023
1	Phenobarbital (Luminal)FDA Link 01/2023
1	LigandsIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Docetaxel (Taxotere)FDA Link 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	E 10 (E-10)IBA 12/2021
1	Ataxia Telangiectasia Mutated ProteinsIBA 01/2020
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2020
1	Adenosine Diphosphate (ADP)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	cyclopropapyrroloindoleIBA 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2019
1	Coloring Agents (Dyes)IBA 12/2018
1	Sirolimus (Rapamycin)FDA Link 11/2018
1	CateninsIBA 01/2018
1	Radium-223IBA 01/2018
1	Programmed Cell Death 1 ReceptorIBA 01/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 12/2017
1	EnzymesIBA 10/2016
1	Checkpoint Kinase 2IBA 01/2016
1	Tyrosine Kinase InhibitorsIBA 10/2015
1	Phosphotransferases (Kinase)IBA 10/2015
1	Amino Acids FDA Link 02/2015
1	A-Form DNA (A-DNA)IBA 12/2014
1	Aurora Kinase AIBA 08/2014
1	Cetuximab (Erbitux)FDA Link 01/2011
1	Panitumumab (Vectibix)FDA Link 01/2011
1	Monoclonal AntibodiesIBA 01/2011

Therapy/Procedure

33	Therapeutics 04/2024 - 01/2011
19	Castration 04/2024 - 05/2015
6	Precision Medicine 01/2023 - 05/2015
6	Drug Therapy (Chemotherapy) 12/2021 - 01/2016
5	Immunotherapy 01/2021 - 01/2017
4	Prostatectomy (Retropubic Prostatectomy) 01/2019 - 10/2016
1	Radiotherapy 01/2022
1	Infant Equipment (Crib) 01/2021
1	Molecular Targeted Therapy 01/2018